Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites. - Trotta AM; Tomassi S; Di Maiolo G; Ieranò C; Vetrei C; D'Alterio C; Merlino F; Messere A; D'Aniello A; Del Bene A; Mazzarella V; Roggia M; et al. (European journal of medicinal chemistry, 2024)